DESANTIS, VANESSA
 Distribuzione geografica
Continente #
NA - Nord America 1.415
EU - Europa 320
AS - Asia 129
SA - Sud America 2
OC - Oceania 1
Totale 1.867
Nazione #
US - Stati Uniti d'America 1.414
SE - Svezia 127
CN - Cina 96
IT - Italia 93
GB - Regno Unito 23
FR - Francia 18
DE - Germania 17
VN - Vietnam 17
FI - Finlandia 12
IN - India 9
BE - Belgio 5
ES - Italia 4
CH - Svizzera 3
IE - Irlanda 3
NL - Olanda 3
UA - Ucraina 3
DK - Danimarca 2
HK - Hong Kong 2
IR - Iran 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BY - Bielorussia 1
CA - Canada 1
CL - Cile 1
EE - Estonia 1
IL - Israele 1
LU - Lussemburgo 1
NO - Norvegia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
VE - Venezuela 1
Totale 1.867
Città #
Chandler 222
Fairfield 172
Woodbridge 130
Ashburn 129
Nyköping 120
Cambridge 81
Seattle 78
New York 69
Houston 65
Wilmington 65
Ann Arbor 60
Bari 42
Beijing 36
Lawrence 27
Roxbury 26
Dearborn 19
Nanjing 19
Inglewood 18
Des Moines 17
Dong Ket 17
Rome 14
Marseille 11
San Diego 11
Grafing 10
Brooklyn 8
Princeton 8
Washington 8
Hebei 7
London 7
Helsinki 6
Brussels 5
Jacksonville 5
Los Angeles 5
Paris 5
Pune 5
Rotherham 4
Tianjin 4
Changsha 3
Dublin 3
Geneva 3
Grumo Appula 3
Jiaxing 3
Jinan 3
Lodi 3
Nanchang 3
Ningbo 3
Redwood City 3
Suri 3
Alcorcón 2
Ardabil 2
Augusta 2
Brescia 2
Chicago 2
Hefei 2
Hong Kong 2
Las Rozas de Madrid 2
Leverano 2
New Bedfont 2
New Haven 2
Padova 2
Shenyang 2
Acton 1
Amsterdam 1
Arzano 1
Baotou 1
Barletta 1
Boardman 1
Bratislava 1
Chiswick 1
Copenhagen 1
Dubai 1
Durham 1
Graz 1
Guangzhou 1
Gurgaon 1
Hangzhou 1
Kilburn 1
Kunming 1
Kyiv 1
Las Vegas 1
Leipzig 1
Lequile 1
Luxembourg 1
Manisa 1
Markham 1
Mestre 1
Minsk 1
Modugno 1
Radeberg 1
Redmond 1
San Donà di Piave 1
San Francisco 1
San Mateo 1
Simi Valley 1
St Louis 1
Sydney 1
Taizhou 1
Tallinn 1
Tappahannock 1
Trani 1
Totale 1.633
Nome #
Isolation and characterization of neural stem cells from dystrophic mdx mouse 133
Microenvironment drug resistance in multiple myeloma: Emerging new players 118
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 116
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 115
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 99
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 93
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 91
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 90
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 86
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 82
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 80
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 79
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 76
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 74
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance” 67
Erratum: Corrigendum to “Isolation and characterization of neural stem cells from dystrophic mdx mouse” (Experimental Cell Research (2016) 343(1) (190–207) (S0014482716300593) (10.1016/j.yexcr.2016.03.019)) 64
The role of SIRT6 in tumors 54
“miRNAs profile of bone marrow fibroblasts in multiple myeloma: relationship with disease progression and drug-resistance” 44
null 43
null 39
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 36
Diabetes and alzheimer’s disease: Might mitochondrial dysfunction help deciphering the common path? 30
Myeloma cells regulate {miRNA} transfer from fibroblast-derived exosomes by expression of {lncRNAs} 30
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 29
Antiangiogenic drugs as chemosensitizers in hematological tumors 24
FGF trapping inhibits multiple myeloma growth through c-Myc degradation–induced mitochondrial oxidative stress 23
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 22
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 22
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 22
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 21
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 20
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion 19
Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, ex vivo and in vitro Analysis 18
A Challenging Case of Visceral Leishmaniasis 17
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure 14
microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation 11
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 10
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 9
Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression 8
Targeting the immune microenvironment in Waldenström Macroglobulinemia via halting the CD40/CD40-ligand axis 7
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 6
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 6
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 6
The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value 5
Mast Cells and Interleukins 3
Changes in Lipids in Granulomatosis with Polyangiitis Relates to Glucocorticoids and History of Hypertension 1
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study 1
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 1
Navigating Lymphomas through BCR Signaling and Double-Hit Insights: Overview 1
Correlation between atrial cardiomyopathy and predictive biomarkers of cryptogenic stroke in primary and secondary prophylaxis: potential role of endothelial progenitor cell (EPCs) dysfunction 1
Totale 2.066
Categoria #
all - tutte 10.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.108


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201971 0 0 0 0 0 0 0 0 0 0 35 36
2019/2020412 50 14 11 30 34 40 49 48 51 34 37 14
2020/2021410 9 16 19 24 84 29 47 33 30 56 29 34
2021/2022252 11 18 4 10 8 17 14 11 19 26 38 76
2022/2023482 44 83 40 49 41 66 9 58 69 10 11 2
2023/2024265 20 27 18 23 32 109 7 12 0 17 0 0
Totale 2.066